Skip to main content
Livermore
Livermore
ZHEN

First Trust Advisors LP

SEC CIK
0001125816
Latest filing
Aug 11, 2026

LGND holding history

Ligand Pharmaceuticals Inc in every 13F filed by First Trust Advisors LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

LGND overviewAll 13F holders of LGNDFull Q2 2026 holdings

Shares (Q2 2026)
90,893
Value
$28.7M
% of portfolio
<0.1%
Quarters held
20
Since Q2 2021
Holdings of LGND by First Trust Advisors LP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202690,893$28.7M<0.1%+10,492+13.0%AddedHolders
Q1 202680,401$16.1M<0.1%+11,181+16.2%AddedHolders
Q4 202569,220$13.1M<0.1%+17,532+33.9%AddedHolders
Q3 202551,688$9.16M<0.1%+2,848+5.8%AddedHolders
Q2 202548,840$5.55M<0.1%+16,570+51.3%AddedHolders
Q1 202532,270$3.39M<0.1%−1,056−3.2%ReducedHolders
Q4 202433,326$3.57M<0.1%−2,011−5.7%ReducedHolders
Q3 202435,337$3.54M<0.1%+3,502+11.0%AddedHolders
Q2 202431,835$2.68M<0.1%+11,110+53.6%AddedHolders
Q1 202420,725$1.51M<0.1%−492−2.3%ReducedHolders
Q4 202321,217$1.52M<0.1%+3,262+18.2%AddedHolders
Q3 202317,955$1.08M<0.1%+17,955NewHolders
Q2 20230$00.0%−16,955−100.0%Sold outHolders
Q1 202316,955$1.25M<0.1%+12,677+296.3%AddedHolders
Q4 20224,278$285.8K<0.1%−6,721−61.1%ReducedHolders
Q3 202210,999$947.0K<0.1%−2,833−20.5%ReducedHolders
Q2 202213,832$1.23M<0.1%+5,883+74.0%AddedHolders
Q1 20227,949$894.0K<0.1%+3,679+86.2%AddedHolders
Q4 20214,270$660.0K<0.1%−8,279−66.0%ReducedHolders
Q3 202112,549$1.75M<0.1%−19,577−60.9%ReducedHolders
Q2 202132,126$4.21M<0.1%+32,126NewHolders